Areas of Focus
- Animal models and therapeutic targets for cerebrovascular diseases
- Development of cerebrovascular recanalization drugs based on nanomaterials
- Blood-brain barrier dysfunction and central nervous system inflammation
Work Experience
- 2017-07~2023-08 - Shenzhen Institutes of Advanced Technology, Chinese Academy of Sciences - Associate Researcher
- 2016-08~2017-06 - Tianjin Institute of Pharmaceutical Research New Drug Evaluation Co., Ltd. - Assistant Researcher
- 2013-08~2016-07 - Institute of Materia Medica, Chinese Academy of Medical Sciences - Medical Doctor
- 2010-08~2013-07 - Tianjin University of Traditional Chinese Medicine - Medical Master
- 2005-08~2009-07 - Tianjin University of Traditional Chinese Medicine - Bachelor of Science
Academic Background & Achievements
- 2013-08--2016-07 Medical Doctor: Institute of Materia Medica, Chinese Academy of Medical Sciences
- 2010-08--2013-07 Medical Master: Tianjin University of Traditional Chinese Medicine
- 2005-08--2009-07 Bachelor of Science: Tianjin University of Traditional Chinese Medicine
Publications
- Obesity-induced blood-brain barrier dysfunction: phenotypes and mechanisms, Third Author, Corresponding Author, 2024
- Remote ischemic conditioning attenuates blood-brain barrier disruption after recombinant tissue plasminogen activator treatment via reducing PDGF-CC, Second Author, 2023
- An MMP-9 exclusive neutralizing antibody attenuates blood-brain barrier breakdown in mice with stroke and reduces stroke patient-derived MMP-9 activity, Third Author, 2023
- Activation of Wnt/Beta-Catenin Signaling Pathway as a Promising Therapeutic Candidate for Cerebral Ischemia/Reperfusion Injury, Sixth Author, Corresponding Author, 2022
- Spatiotemporal lipidomics reveals key features of brain lipid dynamic changes after cerebral ischemia and reperfusion therapy, First Author, 2022
- The Role of Immune Cells in Post-Stroke Angiogenesis and Neuronal Remodeling: The Known and the Unknown, First Author, 2021
- The tissue origin of human mesenchymal stem cells dictates their therapeutic efficacy on glucose and lipid metabolic disorders in type II diabetic mice, First Author, 2021
- Biological Functions and Regulatory Mechanisms of Hypoxia-Inducible Factor-1α in Ischemic Stroke, Second Author, 2021
Awards
- Beijing Science and Technology Award - Science and Technology Progress Award, Second Prize, Provincial Level, 2022